483 The Procter & Gamble Manufacturing Company Nov 2017

483 The Procter & Gamble Manufacturing Company Nov 2017

Tajah Blackburn FDA, Susan Oladeji FDA$119.00 - Available Now

FDA investigators audited the The Procter & Gamble Manufacturing Company - Greensboro, NC, United States facility and issued inspectional observations (via FDA 483) on 17 Nov 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 17 Nov 2017
  • Location: Greensboro, United States
  • FEI: 1017175
Add To Cart